PTPRC and myocardial infarction: Bartko et al. [18] hypothesized that circulating bone marrow-derived cells differentiated into CD45+ cells (fibrocytes) at the injury site and observed that losartan blocked the EndMT on mitral valve endothelium after myocardial infarction showing lower expression of CD45+ cells.